Cargando…

Intravenous Amantadine for Freezing of Gait Resistant to Dopaminergic Therapy: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Clinical Trial

BACKGROUND: Freezing of gait (FOG) is one of the most disabling symptoms in Parkinsonism. Open-label studies have suggested that intravenous (IV) amantadine is effective against FOG resistant to dopaminergic therapy in Parkinson's disease (PD). We evaluated the efficacy of IV amantadine on FOG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Young Eun, Yun, Ji Young, Yang, Hui June, Kim, Han-Joon, Gu, Namyi, Yoon, Seo Hyun, Cho, Joo-Youn, Jeon, Beom S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501515/ https://www.ncbi.nlm.nih.gov/pubmed/23185280 http://dx.doi.org/10.1371/journal.pone.0048890

Ejemplares similares

Amantadine Induced Corneal Edema in a Patient with Primary Progressive Freezing of Gait
por: Kim, Young Eun, et al.
Publicado: (2013)

Paraneoplastic Chorea Managed with Intravenous Amantadine
por: Doher, Nicholas, et al.
Publicado: (2019)

Investigation of the Long-Term Effects of Amantadine Use in Parkinson’s Disease
por: Park, Sangmin, et al.
Publicado: (2023)

Anti-CV2/CRMP5 Paraneoplastic Chorea Effectively Managed with Intravenous Amantadine
por: Ha, Jongmok, et al.
Publicado: (2019)

Dopaminergic pathways and resting-state functional connectivity in Parkinson’s disease with freezing of gait
por: Steidel, Kenan, et al.
Publicado: (2021)

Exploring the levodopa-paradox of freezing of gait in dopaminergic medication-naïve Parkinson’s disease populations
por: Jansen, Jamie A. F., et al.
Publicado: (2023)

Nanomolar concentration of alpha-synuclein enhances dopaminergic neuronal survival via Akt pathway
por: Kim, Ji-Young, et al.
Publicado: (2013)

Preliminary Study of Intravenous Amantadine Treatment for Ataxia Management in Patients with Probable Multiple System Atrophy with Predominant Cerebellar Ataxia
por: Youn, Jinyoung, et al.
Publicado: (2012)

Amantadine for COVID-19 treatment (ACT study): a randomized, double-blinded, placebo-controlled clinical trial
por: Weis, Nina, et al.
Publicado: (2023)

Amantadine and the Risk of Dyskinesia in Patients with Early Parkinson’s Disease: An Open-Label, Pragmatic Trial
por: Kim, Aryun, et al.
Publicado: (2018)

A first-in-human, double-blind, placebo-controlled, randomized, dose escalation study of DWP05195, a novel TRPV1 antagonist, in healthy volunteers
por: Lee, Jieon, et al.
Publicado: (2017)

A practical method for the detection of freezing of gait in patients with Parkinson’s disease
por: Kwon, Yuri, et al.
Publicado: (2014)

Efficacy of amantadine in patients hospitalized with COVID-19: Study protocol of a randomized, double-blind, placebo-controlled trial
por: Lopiano, Leonardo, et al.
Publicado: (2021)

Brain metabolism in patients with freezing of gait after hypoxic-ischemic brain injury: A pilot study
por: Yoon, Seo Yeon, et al.
Publicado: (2017)

Dural Arteriovenous Fistula-Associated Reversible Parkinsonism with Presynaptic Dopaminergic Loss
por: Kim, Hang Rai, et al.
Publicado: (2015)

Efficacy of oral amantadine among patients hospitalised with COVID-19: A randomised, double-blind, placebo-controlled, multicentre study
por: Barczyk, Adam, et al.
Publicado: (2023)

Neuroimaging of Freezing of Gait
por: Fasano, Alfonso, et al.
Publicado: (2015)

Dopaminergic pathway and primary visual cortex are involved in the freezing of gait in Parkinson’s disease: a PET-CT study
por: Zhou, Yongtao, et al.
Publicado: (2019)

Efficacy of cumulative high-frequency rTMS on freezing of gait in Parkinson’s disease
por: Kim, Min Su, et al.
Publicado: (2015)

The Practicalities of Assessing Freezing of Gait
por: Barthel, Claudia, et al.
Publicado: (2016)

Freezing of Gait Before Levodopa
por: Nonnekes, Jorik, et al.
Publicado: (2021)

The Safety and Efficacy of 1-Monoeicosapentaenoin Isolated from the Trebouxiophyceae Micractinium on Anti-Wrinkle: A Split-Face Randomized, Double-Blind Placebo-Controlled Clinical Study
por: Kim, Ki Mo, et al.
Publicado: (2023)

Adaptations to Postural Perturbations in Patients With Freezing of Gait
por: Bekkers, Esther M. J., et al.
Publicado: (2018)

Associations Between Amantadine Usage, Gait, and Cognition in PSP: A post-hoc Analysis of the Davunetide Trial
por: Dale, Marian L., et al.
Publicado: (2020)

Effect of Repeated Intravenous Amantadine Infusions in Patients with Parkinson's Disease: An Open‐Label Pilot Study
por: Khlebtovsky, Alexander, et al.
Publicado: (2019)

Striatal Dopaminergic Functioning in Patients with Sporadic and Hereditary Spastic Paraplegias with Parkinsonism
por: Kim, Ji Seon, et al.
Publicado: (2013)

Efficacy and safety of oral palmitoleic acid supplementation for skin barrier improvement: A 12-week, randomized, double-blinded, placebo-controlled study
por: Koh, Young Gue, et al.
Publicado: (2023)

Gait Initiation Impairment in Patients with Parkinson’s Disease and Freezing of Gait
por: Palmisano, Chiara, et al.
Publicado: (2022)

Amantadine, COVID-19 and Parkinsonism
por: Wiwanitkit, Viroj
Publicado: (2020)

Freezing of Gait in Multiple System Atrophy
por: Yang, Huaguang, et al.
Publicado: (2022)

Amantadine Effect on Perceptions of Irritability after Traumatic Brain Injury: Results of the Amantadine Irritability Multisite Study
por: Hammond, Flora M., et al.
Publicado: (2015)

Gait-Related Brain Activity in People with Parkinson Disease with Freezing of Gait
por: Peterson, Daniel S., et al.
Publicado: (2014)

Dealing with the heterogeneous presentations of freezing of gait: how reliable are the freezing index and heart rate for freezing detection?
por: Cockx, Helena, et al.
Publicado: (2023)

The efficacy and safety of Codonopsis lanceolata water extract for sarcopenia: A study protocol for randomized, double-blind, placebo-controlled clinical trial
por: Park, Jaehyeon, et al.
Publicado: (2022)

Freezing during tapping tasks in patients with advanced Parkinson’s disease and freezing of gait
por: Delval, Arnaud, et al.
Publicado: (2017)

Spatiotemporal Characteristics of Freezing of Gait in Patients After Hypoxic-Ischemic Brain Injury: A Pilot Study
por: Yoon, Seo Yeon, et al.
Publicado: (2016)

A Phase 3, double-blind, placebo-controlled efficacy and safety study of ADS-5102 (Amantadine) extended-release capsules in people with multiple sclerosis and walking impairment
por: Cohen, Jeffrey A, et al.
Publicado: (2021)

Acute Subdural Hematoma Following Spinal Cerebrospinal Fluid Drainage in a Patient with Freezing of Gait
por: Kim, Han-Joon, et al.
Publicado: (2009)

Facilitatory rTMS over the Supplementary Motor Cortex Impedes Gait Performance in Parkinson Patients with Freezing of Gait
por: Brugger, Florian, et al.
Publicado: (2021)

Freezing of Gait in Parkinson’s Disease: An Overload Problem?
por: Beck, Eric N., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5rtvcbqhba6p4i4j9ucl66lan1